CLI-OJEU-50937 Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry (Великобритания (Англия, Шотландия, Уэльс) - Тендер #37763325)

Print or Save this Notice Download PDF Download HTML Download XML

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting authority

I.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Alder House, Alder Court, St Asaph Business Park

St Asaph

LL17 0JL

UK

Telephone: +44 1443848585

E-mail: Joanne.liddle@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

www.etenderwales.bravosolution.co.uk

Additional information can be obtained from the abovementioned address

Tenders or requests to participate must be sent electronically to:

www.etenderwales.bravosolution.co.uk

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

CLI-OJEU-50937 Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry

Reference number: CLI-OJEU-50937

II.1.2) Main CPV code

85121200

II.1.3) Type of contract

Services

II.1.4) Short description

NWSSP Procurement Services, hosted by Velindre University NHS Trust, and the Welsh Bone Marrow Donor Registry (WBMDR), part of Welsh Blood Service, are seeking to appoint a suitably qualified contractor to perform Ultra-High Resolution HLA Typing.

The Welsh Bone Marrow Donor Registry (WBMDR) recruits volunteer donors via blood sample and cheek swab (buccal swab) to support stem cell transplantation. The WBMDR has different typing and testing requirements depending on sample type:

For whole blood samples: We require Ultra High Resolution (UHR) HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1 and DRB3/4/5 HLA typing. The provision of CCR5 testing from whole blood samples is desirable.

For cheek swab samples: We require Ultra High Resolution (UHR) HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1 and DRB3/4/5 HLA typing as well as ABO/Rh and CMV testing.

Please refer to the Specification within the Invitation to Tender document.

II.1.5) Estimated total value

Value excluding VAT: 960 000.00 GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

85111810

II.2.3) Place of performance

NUTS code:

UKL

II.2.4) Description of the procurement

NHS Wales Shared Services Partnership, Procurement Services hosted by Velindre University NHS Trust is looking to award a contract for Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry (a division of Welsh Blood Service) by inviting Bidders to tender for this ITT.

The WBMDR oversees the recruitment of unrelated bone marrow volunteer donors and has an agreed target of recruiting 4000 new donors to the WBMDR stem cell donor panel each year.

Bidders must be able to deliver the HLA types of at least 4000 stem cell donors per annum at ultra-high resolution typing level for HLA-A, B, C, DRB1, DQB1 and DPB1 using next generation sequencing approach. Bidders must be able to deliver the HLA types of at least 4,000 stem cell donors per annum at allele level typing level for HLA-A, B, C, DRB1, DQB1 and DPB1 using a next generation sequencing approach (NGS).

Please refer to the Specification found at Appendix A of the ITT document for full information.

The contract will be for an initial period of three (3) years with the option to extend for a further two (2) years (maximum five year contract).

II.2.5) Award criteria

Criteria below:

Quality criterion: Core Requirements / Weighting: 20

Quality criterion: HLA Result Reporting / Weighting: 10

Quality criterion: Novel HLA Alleles / Weighting: 5

Quality criterion: Timescales/Key Performance indicators / Weighting: 5

Quality criterion: Service Levels & Performance / Weighting: 10

Quality criterion: Reporting of Results / Weighting: 10

Price / Weighting: 40

II.2.6) Estimated value

Value excluding VAT: 960 000.00 GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/07/2023

End: 30/06/2026

This contract is subject to renewal: Yes

Description of renewals:

Option to extend contract for a further two (2) years to 30/06/2028

II.2.9) Information about the limits on the number of candidates to be invited II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

As set out in ITT documents

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

III.2) Conditions related to the contract

III.2.1) Information about a particular profession

Participation is reserved to a particular profession: Yes

Reference to the relevant law, regulation or administrative provision:

Must be accredited to the standards set out within the procurement documents

III.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2022/S 000-020483

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 07/03/2023

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 6 (from the date stated for receipt of tender)

IV.2.7) Conditions for opening of tenders

Date: 07/03/2023

Local time: 12:30

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

VI.3) Additional information

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128474

(WA Ref:128474)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

25/01/2023

Information added to the notice since publication.

Additional information added to the notice since it"s publication.

Commodity Categories

Commodity Categories

Delivery Locations

Delivery Locations

Alert Region Restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

Alert Region Restrictions

Источник закупки

Перейти

Импорт - Экспорт по стране Великобритания (Англия, Шотландия, Уэльс)